We have previously reported CNS and locomotor deficits in KCC3 knockout mice, an animal model of agenesis of the corpus callosum associated with peripheral neuropathy (ACCPN) [Howard, H.C., Mount, D.B., Rochefort, D., Byun, N., Dupre, N., Lu, J., Fan, X., Song, L., Riviere, J.B., Prevost, C., Horst, J., Simonati, A., Lemcke, B., Welch, R., England, R., Zhan, F.Q., Mercado, A., Siesser, W.B., George, A.L., Jr., McDonald, M.P., Bouchard, J.P., Mathieu, J., Delpire, E., Rouleau, G.A., 2002. The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum. Nat. Genet. 32,[384][385][386][387][388][389][390][391][392]. To assess the role of KCC3 in peripheral axon and/or myelin development and maintenance, we determined its expression and performed a detailed morphometric analysis of sciatic nerves. Sciatic nerves of juvenile wildtype mice, but not of adult, express KCC3. In the knockout, Schwann cell/myelin development appears normal at P3, but axons are swollen. At P8 and into P30, some fibers accumulate fluid periaxonally. These initial swelling pathologies are followed by axon and myelin degeneration in adult nerves, leading to reduction in nerve conduction velocity. Mutant mice also exhibit decreased sensitivity to noxious pain. This evidence for fluid-related axonopathy, which ultimately result in neurodegeneration, implicates cell volume regulation as a critical component of peripheral nerve maintenance.
Introduction
Peripheral neuropathy and mental retardation are the pathological hallmarks of the neurological disorder ACCPN (OMIM 218000) and are often associated with variable agenesis of the corpus callosum (ACC), areflexia, and psychosis. The course of peripheral neuropathy, regardless of ACC, begins with hypotonia during infancy, delayed motor milestones, then wheelchair confinement in early adolescence (Dupre et al., 2003; Howard et al., 2002) . Mutations in SLC12A6 (solute carrier 12A6; human KCC3 gene) resulting in truncated nonfunctional protein were identified in ACCPN patients by single-strand conformation polymorphism analysis (Howard et al., 2002) .
In parallel to the genetic study, we produced KCC3 knockout mice that exhibited locomotor deficits by~2 weeks, first low posture indicating limb weakness then hindleg dragging. Poor performance on rotorod, wire-hang, and beam tasks and CNS deficits of significantly low exploratory behavior and abnormal prepulse inhibition confirmed the mouse as a good model of ACCPN (Howard et al., 2002) . Boettger et al. found in their independent KCC3
−/− line hypertension, age-related deafness, increased seizure susceptibility, and a similar peripheral neuropathy phenotype (Boettger et al., 2003 (Hiki et al., 1999; Mount et al., 1999; Race et al., 1999) , KCC3 regulates renal tubule and hippocampal cell volume and has been implicated in ion homeostasis (Boettger et al., 2003) and cell proliferation (Hsu et al., 2007; Shen et al., 2000 Shen et al., 2001 . KCC3 is expressed in brain, spinal cord, and dorsal root ganglia (DRG) neurons (Boettger et al., 2003; Pearson et al., 2001 ), but despite its broad expression (kidney, heart, pancreas, muscle, lung) (Hiki et al., 1999; Mount et al., 1999; Pearson et al., 2001) , its loss of function predominantly involves the central and peripheral nervous systems (Dupre et al., 2003; Howard et al., 2002) . The peripheral nerve pathology, however, remained puzzling since KCC3 expression had not yet been demonstrated in sciatic nerves (Boettger et al., 2003; Pearson et al., 2001 
